Portal and systemic serum growth factor and acute-phase response after laparotomy or partial hepatectomy in patients with colorectal liver metastases: a prognostic role for C-reactive protein and hepatocyte growth factor

References

• Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:59–71.
   Web of Science ®Google Scholar
• de Jong KP, Slooff MJH, de Vries EGE, Brouwers MAM, Terpstra OT. Effect of partial liver resection on tumour growth. J Hepatol 1996;25:109–21.
   Google Scholar
• Stolz DB, Mars WM, Petersen BE, Kim TH, Michalopoulos GK. Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat. Cancer Res 1999;59:3954–60.
   Google Scholar
• Radinsky R. Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment. Cancer Metastasis Rev 1995;14:323–38.
   PubMedGoogle Scholar
• Adzick NS, Lorenz HP. Cells, matrix, growth factors, and the surgeon. The biology of scarless fetal wound repair. Ann Surg 1994;220:10–8.
   Google Scholar
• Harding KG, Morris HL, Patel GK. Science, medicine and the future: healing chronic wounds. Br Med J 2002;324:160–3.
   Google Scholar
• Murphy LJ, Bell GI, Friesen HG. Tissue distribution of insulinlike growth factor I and II messenger ribonucleic acid in the adult rat. Endocrinology 1987;120:1279–82.
   Google Scholar
• St Hilaire RJ, Hradek GT, Jones AL. Hepatic sequestration and biliary secretion of epidermal growth factor: evidence for a highcapacity uptake system. Proc Natl Acad Sci USA 1983;80:3797–801.
   Google Scholar
• Van Thiel DH, Hagler NG, Schade RR, Skolnick ML, Heyl AP, Rosenblum E, et al. In vivo hepatic volume determination using sonography and computed tomography. Validation and a comparison of the two techniques. Gastroenterology 1985; 88: 1812–7.
   Google Scholar
• Taniguchi T, Kitamura M, Arai K, Iwasaki Y, Yamamoto Y, Igari A, et al. Increase in the circulating level of hepatocyte growth factor in gastric cancer patients. Br J Cancer 1997; 75: 673–7.
   PubMed Web of Science ®Google Scholar
• Gohji K, Nomi M, Niitani Y, Kitazawa S, Fujii A, Katsuoka Y, et al. Independent prognostic value of serum hepatocyte growth factor in bladder cancer. J Clin Oncol 2000;18:2963–71.
   PubMedGoogle Scholar
• Yu H, Mistry J, Nicar MJ, Khosravi J, Diamandis A, van Doorn J, et al. Insulin-like growth factors (IGF-I, free IGF-I, and IGF-II) and insulin-like growth factor binding proteins (IFGBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. J Clin Lab Anal 1999;13: 166–72.
   Google Scholar
• Helle M, Boeye L, de Groot E, de Vos A, Aarden LA. Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera. J Immunol Methods 1991;138: 47–56.
   Google Scholar
• Hazenberg BPC, Limburg PC, Bijzet J, van Rijswijk MH. Monoclonal antibody based ELISA for human SAA. In: Natvig JB, Forre O, Husby G, Husebekk A, Skogen B, Sletten K, et al, editors. Amyloid and amyloidosis. Dordrecht: Kluwer Academic Press; 1991. p. 898–901.
   Google Scholar
• Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230: 309–18.
   Google Scholar
• Picardo A, Karpoff HM, Bruce Ng, Lee J, Brennan MF, Fong Y. Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery 1998;124:57–64.
   PubMed Web of Science ®Google Scholar
• Nicolson GL. Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. Exp Cell Res 1993;204:171–80.
   PubMedGoogle Scholar
• Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM, Fidler IJ. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res 1988;48:1943–8.
   PubMed Web of Science ®Google Scholar
• Asaga T, Suzuki K, Umeda M, Sugimasa Y, Takemiya S, Okamoto T. The enhancement of tumor growth after partial hepatectomy and the effect of sera obtained from hepatectomized rats on tumor cell growth. Jpn J Surg 1991;21:669–75.
   PubMedGoogle Scholar
• de Jong KP, Brouwers MAM, van Veen ML, Brinker M, de Vries EGE, Daemen T, et al. Serum obtained from rats after partial hepatectomy enhances growth of cultured colon carcinoma cells. Invasion Metastasis 1998;18:155–64.
   PubMedGoogle Scholar
• Mizutani J, Hiraoka T, Yamashita R, Miyauchi Y. Promotion of hepatic metastases by liver resection in the rat. Br J Cancer 1992; 65:794–7.
   PubMed Web of Science ®Google Scholar
• de Jong KP, Lont HE, Bijma AM, van Veen ML, Brouwers MAM, de Vries EGE, et al. The effect of partial hepatectomy on tumor growth in rats. In vivo and in vitro studies. Hepatology 1995;22:1263–72.
   Google Scholar
• Aldeguer X, Debonera F, Shaked A, Krasinkas AM, Gelman AE, Que X, et al. Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. Hepatology 2002;35:40–8.
   PubMedGoogle Scholar
• Pediaditakis P, Lopez-Talavera JC, Petersen B, Monga SP, Michalopoulos GK. The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology 2001;34:688–93.
   PubMedGoogle Scholar
• Chen MF, Hwang TL, Hung CF. Human liver regeneration after major hepatectomy. A study of liver volume by computed tomography. Ann Surg 1991;213:227–9.
   Google Scholar
• Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, et al. Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology 1995; 21:434–9.
   PubMed Web of Science ®Google Scholar
• Moshage H. Cytokines and the hepatic acute phase response. J Pathol 1997;181:257–66.
   PubMed Web of Science ®Google Scholar
• Ferry JR, Cerri RW, Cohen P. Insulin-like growth factor binding proteins: new proteins, new functions. Horm Res 1999;51:53–67.
   Google Scholar
• Rosen CJ. Serum insulin-like growth factors and insulin-like growth factor-binding proteins: clinical implications. Clin Chem 1999;45:1384–90.
   PubMedGoogle Scholar
• Singh P, Rubin N. Insulinlike growth factors and binding proteins in colon cancer. Gastroenterology 1993;105:1218–37.
   PubMed Web of Science ®Google Scholar
• Guo YS, Narayan S, Yallampalli C, Singh P. Characterization of insulinlike growth factor I receptors in human colon cancer. Gastroenterology 1992;102:1101–8.
   PubMed Web of Science ®Google Scholar
• Baserga R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res 1995;55:249–52.
   PubMed Web of Science ®Google Scholar
• Butt AJ, Firth SM, Baxter RC. The IGF axis and programmed cell death. Immunol Cell Biol 1999;77:256–62.
   PubMedGoogle Scholar
• Butt AJ, Williams AC. IGFBP-3 and apoptosis: a license to kill? Apoptosis 2001;6:199–205.
   PubMedGoogle Scholar
• Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. JNatl Cancer Inst 1999;91:620–5.
   PubMed Web of Science ®Google Scholar
• De Meyts P, Whittaker J. Structural biology of insulin and IGF1 receptors: implications for drug design. Nat Rev Drug Discov 2002;1:769–83.
   PubMed Web of Science ®Google Scholar
• Argilés JM, López-Soriano F. Insulin and cancer. Int J Oncol 2001;18:683–7. Ref. type: Generic.
   Google Scholar
• Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 2002;94: 972–80.
   Google Scholar
• Wong M, Holdaway IM. Insulin binding by normal and neoplastic colon tissue. Int J Cancer 1985;35:335–41.
   PubMedGoogle Scholar
• Tanaka S, Mohr L, Schmidt EV, Sugimachi K, Wands JR. Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes. Hepatology 1997;26: 598–604.
   Google Scholar
• Kalli KR, Falowo OI, Bale LK, Zschunke MA, Roche PC, Conover CA. Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling. Endocrinology 2002;143:3259–67.
   PubMed Web of Science ®Google Scholar
• Chang Q, Li Y, White MF, Fletcher JA, Xiao S. Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications. Cancer Res 2002; 62: 6035–8.
   Google Scholar
• Olsen PS, Boesby S, Kirkegaard P, Therkelsen K, Almdal T, Poulsen SS, et al. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology 1988; 8:992–6.
   PubMedGoogle Scholar
• Raper SE, Burwen SJ, Barker ME, Jones AL. Translocation of epidermal growth factor to the hepatocyte nucleus during rat liver regeneration. Gastroenterology 1987;92:1243–50.
   PubMed Web of Science ®Google Scholar
• Lambotte L, Saliez A, Triest S, Maiter D, Baranski A, Barker A, et al. Effect of sialoadenectomy and epidermal growth factor administration on liver regeneration after partial hepatectomy. Hepatology 1997;25:607–12.
   PubMedGoogle Scholar
• Parker C, Roseman BJ, Bucana CD, Tsan R, Radinsky R. Preferential activation of the epidermal growth factor receptor in human colon carcinoma liver metastases in nude mice. J Histochem Cytochem 1998;46:595–602.
   Google Scholar
• Radinsky R, Risin S, Fan D, Dong Z, Bielenberg D, Bucana CD, et al. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1995;1:19–31.
   PubMed Web of Science ®Google Scholar
• de Jong KP, Stellema R, Karrenbeld A, Koudstaal J, Gouw ASH, Sluiter WJ, et al. Clinical relevance of expression of transforming growth factor alpha, epidermal growth factor receptor, p53 and Ki67 in colorectal liver metastases and corresponding primary tumors. Hepatology 1998;28:971–9.
   PubMed Web of Science ®Google Scholar
• Kimura F, Miyazaki M, Suwa T, Kakizaki S, Itoh H, Kaiho T, et al. Increased levels of human hepatocyte growth factor in serum and peritoneal fluid after partial hepatectomy. Am J Gastroenterol 1996;91:116–21.
   PubMedGoogle Scholar
• McMillan DC, Wotherspoon HA, Fearon KCH, Sturgeon C, Cooke TG, McArdle CS1. A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 1995;170:319–22.
   Google Scholar
• Nielsen HJ, Christensen IJ, Sorensen S, Moesgaard F, BrunnerN. Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group. Ann Surg Oncol 2000;7: 617–23.
   Google Scholar
• Wigmore SJ, MacMahon AJ, Sturgeon CM, Fearon KC. Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer. Br J Surg 2001;88:255–60.
   PubMedGoogle Scholar
• Nozoe T, Matsumata T, Kitamura M, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 1998;176: 335–8.
   PubMed Web of Science ®Google Scholar
• McMillan DC, Canna K, McArdle CS. Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 2003;90:215–9.
   Google Scholar
• Jiang W, Hiscox S, Matsumoto K, Nakamura T. Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol 1999;29:209–48.
   PubMed Web of Science ®Google Scholar
• Fuhrmann-Benzakein E, Ma MN, Rubbia-Brandt L, Mentha G, Ruefenacht D, Sappino AP, et al. Elevated levels of angiogenic cytokines in the plasma of cancer patients. Int J Cancer 2000;85: 40–5.
   PubMedGoogle Scholar
• Xin X, Yang S, Ingle G, Zlot C, Rangell L, Kowalski J, et al. Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am J Pathol 2001;158:1111–20.
   PubMed Web of Science ®Google Scholar
• Shimizu H, Miyazaki M, Wakabayashi Y, Mitsuhashi N, Kato A, Ito H, et al. Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J Hepatol 2001;34:683–9.
   PubMed Web of Science ®Google Scholar
• Belluco C, Nitti D, Frantz M, Toppan P, Basso D, Plebani M, et al. Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer. Ann Surg Oncol 2000;7:133–8.
   PubMed Web of Science ®Google Scholar
• Galizia G, Orditura M, Romano C, Lieto E, Castellano P, Pelosio L, et al. Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clin Immunol 2002;102:169–78.
   PubMed Web of Science ®Google Scholar
• de Jong KP, van Gameren MM, Bijzet J, Limburg PC, Slooff MJH, de Vries EGE. Recombinant human interleukin-6 induces hepatocyte growth factor production in cancer patients. Scand J Gastroenterol 2001;36:636–40.
   PubMedGoogle Scholar